Bruce Ratner has led an eclectic life. After focusing much of his undergraduate coursework on math, biology, and physics, he started his career in law and public service as an assistant professor at New York University Law School and Commissioner of Consumer Affairs under Mayor Ed Koch. In his late 30s, he moved into real estate, becoming one of the city's largest developers. In 2016, Ratner's brother, Michael, died of metastatic cancer. Through this tragedy, Ratner came to realize that early detection was the key to reducing cancer mortality. Following his brother's death, he founded a non-profit, the Michael D. Ratner Center for Early Detection of Cancer, to research and promote better cancer screening. He is on the boards of Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, and the Cold Spring Harbor Laboratory. Adam Bonislawskiis a science writer with more than 10 years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer and early detection. His writing ranges widely over academic research, companies and technologies. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors, and he has scientific and media contacts at many of the major cancer and academic research centers in the United States and Europe. In addition to his work as a science writer, Adam writes about business and real estate for the Wall Street Journal, New York Post, and Commercial Observer.
“Powerful and essential … an exciting—and often personal—scientific saga.” —Siddhartha Mukherjee, author of The Emperor of All Maladies “An engaging, informative and hugely important work that will save lives.” —Ken Burns, Grammy and Emmy Award-winning filmmaker “Deeply personal, insightful and well-reported.” —Katie Couric, journalist and author of Going There “Early Detection provides an important look into testing and treatment disparities that exist in cancer care, and thoughtful guidance about how to mitigate these inequities. Expanding access is in everyone’s best interest as it has the potential to increase the chance of survival while lowering the cost of care.” —Selwyn M. Vickers, MD, President and CEO, Memorial Sloan-Kettering Cancer Center “This clear and thoughtful book is a critical step in the fight against cancer. The authors understand our medical system and have proposed comprehensive policies that will save thousands of lives and help eliminate the detection and treatment disparities that we need to end.” —Richard I. Beattie, Esq former Chairman of the Board, Memorial Sloan-Kettering Cancer Center